OncoCyte Goodwill and Intangible Assets 2014-2024 | OCX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

OncoCyte goodwill and intangible assets from 2014 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

OncoCyte goodwill and intangible assets from 2014 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$121.5B
Cencora (COR)	$44.3B
ICON (ICLR)	$23.6B
DiDi Global (DIDIY)	$23.3B
Avantor (AVTR)	$17.6B
Natera (NTRA)	$15.5B
Revvity (RVTY)	$15.5B
Viatris (VTRS)	$13.8B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$11.7B
Medpace Holdings (MEDP)	$10.3B
Charles River Laboratories (CRL)	$10.2B
Sonic Healthcare (SKHHY)	$9.1B
Doximity (DOCS)	$8B
HealthEquity (HQY)	$7B
Bausch + Lomb (BLCO)	$6.7B
PACS (PACS)	$6B
Organon (OGN)	$4.9B
Life Times (LTH)	$4.8B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.1B
Concentras Parent (CON)	$2.8B
Ardent Health Partners (ARDT)	$2.6B
GoodRx Holdings (GDRX)	$2.6B
BrightSpring Health Services (BTSG)	$2.6B
Alignment Healthcare (ALHC)	$2.2B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$2B
AMN Healthcare Services Inc (AMN)	$1.6B
CareDx (CDNA)	$1.6B